SAN DIEGO, CA--(Marketwire - Oct 23, 2012) - AIS (American Internet Services), a leading provider of enterprise-class data center, cloud, and connectivity services, today unveiled AIS ClearCompute, a Life Sciences Software as a Service (SaaS) platform that supports a growing library of popular research tools including BLAST, Galaxy, and RNA-Seq commonly used by biotech, genomics sequencing, and pharmaceutical scientists. The platform consists of "best-of-breed" compute and storage technologies and leverages AIS' high-speed network connectivity, keen understanding of compliance and regulatory requirements, and close geographic proximity to the Life Sciences community in the Southwestern region.
Cirrhus9, a full service technology and cloud computing system integrator with deep knowledge of the Life Sciences space, worked closely with AIS to develop the AIS ClearCompute platform. Paul Laskin, a co-founder at Cirrhus9 and former IT executive at Pfizer Pharmaceuticals, pointed out how research scientists have been clamoring for easy access to on-demand compute and storage resources where they can run their critical applications in a secure, scalable, high-performance environment.
"Applications outsourcing (AO) is taking off in the Life Sciences industry and companies need confidence that they are dealing with a service provider who has a strong commitment to security and regulatory compliance," said Paul Laskin, co-founder of Cirrhus9. "With a private optical network that runs between multiple data centers in San Diego and Phoenix plus substantial domain expertise and investment, AIS is the ideal 'go-to' partner for any Life Sciences firm wanting to move into the cloud or augment in-house IT infrastructure."
AIS ClearCompute is a virtualization environment that consists of applications and data libraries widely used by the Life Sciences research community. BLAST (Basic Local Alignment Search Tool), one of the initial applications, compares sequence data to publicly available and / or private data sets to identify regions of local similarity. Using AIS ClearCompute, the pattern matching speed will be greatly accelerated. Similarly, Galaxy is an open, web-based platform for performing accessible, reproducible, and transparent genomic science, while RNA-Seq refers to the use of high-throughput sequencing technologies.
"By combining efforts with the industry veterans at Cirrhus9, AIS developed ClearCompute to address significant pent-up demand within biotech and genomics sequencing firms for easy access to cost-effective, massively scalable computing," said Tim Caulfield, chief executive officer at AIS. "The Life Sciences market is a strategic vertical for AIS, and we understand the critical importance of accelerating scientists' development efforts through easy, affordable access to a growing bench of popular tools such as BLAST, Galaxy, and RNA-Seq."
AIS ClearCompute joins the company's existing cloud computing portfolio that consists of AIS BusinessCloud1, San Diego's first full-featured VMware-based cloud service built with state-of-the-art compute, network, and storage technologies optimized for security, performance, and reliability. AIS BusinessCloud1, which is also available in Phoenix, Arizona, provides small, medium, and enterprise customers a flexible migration path to the cloud for IT infrastructure expansion, disaster recovery, and test/development applications.
AIS ClearCompute is available now. To schedule a complimentary trial or for more information on AIS ClearCompute, please visit www.americanis.net/AIS-ClearCompute.
About American Internet Services
American Internet Services (AIS) is an enterprise-class data center, cloud and managed services company known for its robust network, security and solutions engineering capabilities that help companies get the most out of their information technology initiatives. AIS operates secure, SSAE 16-compliant facilities in Los Angeles, San Diego and Phoenix, providing geographical diversity and redundant connectivity to create effective business continuity solutions. Expanding its portfolio into cloud services, AIS provides enterprise-grade, highly scalable Infrastructure as a Service (IaaS) alongside traditional managed services (load balancing, security and archiving). By maintaining a focus on leading-edge technologies, AIS has become a recognized leader in delivering cloud strategies for the Bioinformatics and Life Sciences industries. In business for over 20 years, AIS is privately held - backed by Seaport Capital, Viridian Investments, and DuPont Capital Management. For more information, visit www.americanis.net or call (866) 971-2656.
VMware and vCloud Director are registered trademarks and/or trademarks of VMware, Inc. in the United States and/or other jurisdictions. The use of the word "partner" or "partnership" does not imply a legal partnership relationship between VMware and any other company.